AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 132 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $20,000 | -99.9% | 584 | -100.0% | 0.00% | -100.0% |
| Q2 2020 | $38,538,000 | +4.6% | 2,306,209 | -9.8% | 0.00% | -20.0% |
| Q1 2020 | $36,857,000 | -61.7% | 2,555,931 | -11.1% | 0.01% | -54.5% |
| Q4 2019 | $96,269,000 | +90.6% | 2,876,283 | +19.2% | 0.01% | +83.3% |
| Q3 2019 | $50,520,000 | +0.6% | 2,412,585 | +0.0% | 0.01% | 0.0% |
| Q2 2019 | $50,209,000 | -17.8% | 2,411,582 | -11.8% | 0.01% | -14.3% |
| Q1 2019 | $61,117,000 | +21.7% | 2,734,583 | +30.3% | 0.01% | 0.0% |
| Q4 2018 | $50,213,000 | -12.8% | 2,099,221 | -0.5% | 0.01% | +16.7% |
| Q3 2018 | $57,574,000 | -15.2% | 2,110,481 | -16.4% | 0.01% | -25.0% |
| Q2 2018 | $67,880,000 | -24.2% | 2,524,371 | -10.3% | 0.01% | -27.3% |
| Q1 2018 | $89,546,000 | -7.9% | 2,813,271 | +9.5% | 0.01% | 0.0% |
| Q4 2017 | $97,199,000 | +33.0% | 2,570,040 | -12.8% | 0.01% | +22.2% |
| Q3 2017 | $73,102,000 | +17.9% | 2,948,885 | -2.2% | 0.01% | +12.5% |
| Q2 2017 | $62,011,000 | -18.4% | 3,016,056 | -13.7% | 0.01% | -20.0% |
| Q1 2017 | $75,949,000 | -25.0% | 3,495,159 | -29.4% | 0.01% | -28.6% |
| Q4 2016 | $101,207,000 | +37.4% | 4,949,027 | +0.8% | 0.01% | +40.0% |
| Q3 2016 | $73,677,000 | +39.6% | 4,911,827 | +0.7% | 0.01% | +42.9% |
| Q2 2016 | $52,765,000 | -24.5% | 4,876,567 | -5.4% | 0.01% | -30.0% |
| Q1 2016 | $69,928,000 | -40.2% | 5,156,977 | -18.6% | 0.01% | -37.5% |
| Q4 2015 | $116,925,000 | -24.1% | 6,337,414 | +4.1% | 0.02% | -27.3% |
| Q3 2015 | $154,129,000 | – | 6,087,235 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|